Back to top

Alnylam Pharma (ALNY) Gets a Hold from Wells Fargo

In a report released today, from Wells Fargo maintained a Hold rating on Alnylam Pharma, with a price target of $256.00. In addition to Wells Fargo...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Alnylam Pharmaceuticals, Inc. (ALNY)